At Legend Biotech, we recognize that sustainability is crucial for ensuring the long-term health and success of our organization. It allows us to operate responsibly, reduce our environmental footprint, and contribute positively to society. Last year, we reached an important milestone by publishing our inaugural sustainability report. This report not only laid the foundation for our sustainability strategy but also serves as a roadmap for how we do business, underscoring our commitment to our patients, employees, and our company as a whole.

In our 2024 report, we made significant strides in advancing our Environmental, Social, and Governance (ESG) initiatives. We strengthened our governance structures to ensure strong oversight of our ESG activities. We also included comprehensive health and safety metrics, underscoring our commitment to the well-being of our workforce. Our access to medicines programs were expanded, furthering our dedication to making healthcare accessible to all. Additionally, we enhanced our offerings for employees, recognizing them as our most valuable asset. Beyond these key efforts, we implemented a range of other initiatives to expand our sustainability efforts and drive positive change throughout our operations.

We understand the need to adapt to evolving industry standards and frameworks, and we may incorporate additional ESG metrics and reporting standards in future reports as the market evolves. As we continue to advance our ESG strategy, we remain dedicated to transparently reporting our progress. Our ongoing commitment to ESG principles will guide us in creating a sustainable and equitable future for everyone.